Matches in Wikidata for { <http://www.wikidata.org/entity/Q50065599> ?p ?o ?g. }
- Q50065599 description "2017 nî lūn-bûn" @default.
- Q50065599 description "2017年の論文" @default.
- Q50065599 description "2017年学术文章" @default.
- Q50065599 description "2017年学术文章" @default.
- Q50065599 description "2017年学术文章" @default.
- Q50065599 description "2017年学术文章" @default.
- Q50065599 description "2017年学术文章" @default.
- Q50065599 description "2017年学术文章" @default.
- Q50065599 description "2017年學術文章" @default.
- Q50065599 description "2017年學術文章" @default.
- Q50065599 description "2017年學術文章" @default.
- Q50065599 description "2017年學術文章" @default.
- Q50065599 description "2017年學術文章" @default.
- Q50065599 description "2017년 논문" @default.
- Q50065599 description "article científic" @default.
- Q50065599 description "article scientific" @default.
- Q50065599 description "article scientifique" @default.
- Q50065599 description "articol științific" @default.
- Q50065599 description "articolo scientifico" @default.
- Q50065599 description "artigo científico" @default.
- Q50065599 description "artigo científico" @default.
- Q50065599 description "artigo científico" @default.
- Q50065599 description "artikel ilmiah" @default.
- Q50065599 description "artikull shkencor" @default.
- Q50065599 description "artikulong pang-agham" @default.
- Q50065599 description "artykuł naukowy" @default.
- Q50065599 description "artículo científico publicado en 2017" @default.
- Q50065599 description "artículu científicu" @default.
- Q50065599 description "bilimsel makale" @default.
- Q50065599 description "bài báo khoa học" @default.
- Q50065599 description "naučni članak" @default.
- Q50065599 description "scienca artikolo" @default.
- Q50065599 description "scientific article published on 19 September 2017" @default.
- Q50065599 description "scientific article published on 19 September 2017" @default.
- Q50065599 description "scientific article published on 19 September 2017" @default.
- Q50065599 description "teaduslik artikkel" @default.
- Q50065599 description "tieteellinen artikkeli" @default.
- Q50065599 description "tudományos cikk" @default.
- Q50065599 description "vedecký článok" @default.
- Q50065599 description "vetenskaplig artikel" @default.
- Q50065599 description "videnskabelig artikel" @default.
- Q50065599 description "vitenskapelig artikkel" @default.
- Q50065599 description "vitskapeleg artikkel" @default.
- Q50065599 description "vědecký článek" @default.
- Q50065599 description "wetenschappelijk artikel" @default.
- Q50065599 description "wissenschaftlicher Artikel" @default.
- Q50065599 description "επιστημονικό άρθρο" @default.
- Q50065599 description "мақолаи илмӣ" @default.
- Q50065599 description "наукова стаття, опублікована у вересні 2017" @default.
- Q50065599 description "научна статия" @default.
- Q50065599 description "научная статья" @default.
- Q50065599 description "научни чланак" @default.
- Q50065599 description "научни чланак" @default.
- Q50065599 description "מאמר מדעי" @default.
- Q50065599 description "مقالة علمية نشرت في 19 سبتمبر 2017" @default.
- Q50065599 description "১৯ সেপ্টেম্বর ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q50065599 description "บทความทางวิทยาศาสตร์" @default.
- Q50065599 description "სამეცნიერო სტატია" @default.
- Q50065599 name "Phase 2 Open-Label Study of Bortezomib, Cladribine, and Rituximab in Advanced, Newly Diagnosed, and Relapsed/Refractory Mantle-Cell and Indolent Lymphomas." @default.
- Q50065599 name "Phase 2 Open-Label Study of Bortezomib, Cladribine, and Rituximab in Advanced, Newly Diagnosed, and Relapsed/Refractory Mantle-Cell and Indolent Lymphomas." @default.
- Q50065599 type Item @default.
- Q50065599 label "Phase 2 Open-Label Study of Bortezomib, Cladribine, and Rituximab in Advanced, Newly Diagnosed, and Relapsed/Refractory Mantle-Cell and Indolent Lymphomas." @default.
- Q50065599 label "Phase 2 Open-Label Study of Bortezomib, Cladribine, and Rituximab in Advanced, Newly Diagnosed, and Relapsed/Refractory Mantle-Cell and Indolent Lymphomas." @default.
- Q50065599 prefLabel "Phase 2 Open-Label Study of Bortezomib, Cladribine, and Rituximab in Advanced, Newly Diagnosed, and Relapsed/Refractory Mantle-Cell and Indolent Lymphomas." @default.
- Q50065599 prefLabel "Phase 2 Open-Label Study of Bortezomib, Cladribine, and Rituximab in Advanced, Newly Diagnosed, and Relapsed/Refractory Mantle-Cell and Indolent Lymphomas." @default.
- Q50065599 P1433 Q50065599-0D0CBC9B-A825-4CF2-AD47-18A5B30883D9 @default.
- Q50065599 P1476 Q50065599-998C7D4B-4E43-4C28-A40F-F43976B36AD5 @default.
- Q50065599 P2093 Q50065599-1033A6B2-5784-42A2-A8D3-A246528223BF @default.
- Q50065599 P2093 Q50065599-155E8596-E801-4D83-84C7-85371D963578 @default.
- Q50065599 P2093 Q50065599-2D911577-07F3-4021-B9BB-76B8B374631A @default.
- Q50065599 P2093 Q50065599-60F3464B-577D-4529-9072-4D1EFDD4B7F4 @default.
- Q50065599 P2093 Q50065599-61056312-FF93-4677-BF51-58185FD47F7C @default.
- Q50065599 P2093 Q50065599-C62C28BE-8B24-4140-B559-EB90230DCB33 @default.
- Q50065599 P2093 Q50065599-C8B04906-F926-42E4-A217-72A4C614B0E8 @default.
- Q50065599 P2093 Q50065599-FF8A8FF4-CD65-4114-BB64-6A7539D4E81E @default.
- Q50065599 P304 Q50065599-6BE87595-570C-4302-8975-5B3808EF2416 @default.
- Q50065599 P31 Q50065599-C44F770D-2654-42AF-ABB3-89EF1484997C @default.
- Q50065599 P356 Q50065599-50CB9548-B262-4769-B2CC-FD5965E381B8 @default.
- Q50065599 P407 Q50065599-0BCC3A9D-259A-4B6D-AA93-283D646B954C @default.
- Q50065599 P433 Q50065599-1DD5B866-731F-4570-80BA-49FFFBDB699A @default.
- Q50065599 P478 Q50065599-22F63ADE-110D-477F-B5C9-DD080AF6672D @default.
- Q50065599 P50 Q50065599-348579AE-DD66-49B0-B47A-4DBFCC94D4FC @default.
- Q50065599 P50 Q50065599-908F1632-46E6-43D9-9786-D9FA26ECD129 @default.
- Q50065599 P577 Q50065599-89DA7634-0DAF-40D3-80CC-869A674A10D7 @default.
- Q50065599 P698 Q50065599-88EC7786-D7ED-47A1-9FB3-E17D305D1546 @default.
- Q50065599 P921 Q50065599-71C3F631-CB1F-45D7-A4BC-8EC4CD7582CD @default.
- Q50065599 P356 J.CLML.2017.09.001 @default.
- Q50065599 P698 29056470 @default.
- Q50065599 P1433 Q5133774 @default.
- Q50065599 P1476 "Phase 2 Open-Label Study of Bortezomib, Cladribine, and Rituximab in Advanced, Newly Diagnosed, and Relapsed/Refractory Mantle-Cell and Indolent Lymphomas" @default.
- Q50065599 P2093 "Abhijeet Kumar" @default.
- Q50065599 P2093 "Daniel O Persky" @default.
- Q50065599 P2093 "Daruka Mahadevan" @default.
- Q50065599 P2093 "José Guillen-Rodriguez" @default.
- Q50065599 P2093 "Kara Heard" @default.
- Q50065599 P2093 "Lora Inclán" @default.
- Q50065599 P2093 "Soham D Puvvada" @default.
- Q50065599 P2093 "Xavier I Rivera" @default.
- Q50065599 P304 "58-64" @default.
- Q50065599 P31 Q13442814 @default.